Reducing cardiovascular risks of nonsteroidal anti-inflammatory drugs by using topical formulations.
Robert L
RL
Barkin
D000287:Administration, Topical; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage* / Q000009:adverse effects* / Q000493:pharmacokinetics; D002318:Cardiovascular Diseases / Q000139:chemically induced* / Q000517:prevention & control; D003404:Creatinine / Q000032:analysis; D006801:Humans
D000894:Anti-Inflammatory Agents, Non-Steroidal; D003404:Creatinine